Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PT-141 For Lab Research 44.99 Login for member prices PT-141 (Bremelanotide) is a cyclic melanocortin receptor agonist for laboratory and in vitro research
The SERENA study, a multicenter, randomized, double-blind, placebo-controlled trial, organized and promoted by the Young Italian Endocrinologists Group (EnGioI)Italian Society of Endocrinology, aimed to evaluate the effect of Se supplementation on AIT during and after pregnancy [65]
NC24 Japan Ultra Sense Complexion 9,000,000 mg Glutathione Injection 7-Session Brightening & Rejuvenation Program NC24 Japan Ultra Sense Complexion Glutathione Injection delivers a powerful clinic-ready formula designed for transformative results
The development of GLP-1R, GIPR, and GCGR poly-agonists marks a new era in obesity pharmacotherapy
doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach
US$ 25.56
US$ 25.61
US$ 24.58
US$ 26.47
US$ 23.02
US$ 25.66
US$ 26.89
